Ajinomoto Co., Inc. Completes the Acquisition of a U.S.-based Biopharmaceutical CDMO
Operating under New Company Name: Ajinomoto Althea, Inc.

TOKYO, April 5, 2013 – Ajinomoto Co., Inc. (“Ajinomoto Co.”) announced that today, Friday, April 5, 2013 (April 4 local U.S. time), it completed the procedures to acquire all of the stock of Althea Technologies, Inc. (“Althea”) in accordance with the contents set forth in the press release “Ajinomoto Co., Inc. agrees to acquire Althea Technologies, Inc. a U.S.-based biopharmaceutical CDMO” dated March 6, 2013. With the company as a fully consolidated subsidiary of Ajinomoto Co. under the new name Ajinomoto Althea Inc., Ajinomoto Co. plans to expand the business for contract biopharmaceutical development and manufacturing services in the North American market, and to strengthen the Ajinomoto Group’s advanced biomedical business.

Completion of the Stock Acquisition
As of Friday, April 5, 2013 (April 4 local U.S. time), Ajinomoto Co. completed the acquisition of all of the stock of Althea. The acquisition price was approximately USD 175 million (approx. JPY 16 billion).

Outline of the Company
1. Company name: Ajinomoto Althea, Inc.
2. President & CEO: Rick Hancock
3. Co-Chairs: Hiroshi Shiragami, Ph. D. (Managing Director)
Magda Marquet, Ph. D. (Founder)
4. Headquarters: San Diego, CA, U.S.A.
5. Revenue: Approximately USD 53 million (2012)
6. Number of employees: Approximately 220
7. Business description: Contract development and manufacturing organization providing fill & finish, biologics manufacturing, analytical development, and stability testing services for biopharmaceutical companies

About Ajinomoto Co.
Press release dated March 6, 2013:
“Ajinomoto Co., Inc. agrees to acquire Althea Technologies, Inc., a U.S.-based biopharmaceutical CDMO for approx. USD 175 million”
URL: http://www.ajinomoto.com/en/presscenter/press/detail/g2013_03_06.html

About Ajinomoto Co.
Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. For more about Ajinomoto Co. (TYO: 2802), visit www.ajinomoto.com.
For further information, please contact here.